Related Experiment Videos
Vasculitis and infection with the human immunodeficiency virus
1Department of Rheumatic and Immunologic Disease, Cleveland Clinic, Ohio.
Rheumatic Diseases Clinics of North America
|February 1, 1991
Summary
Human immunodeficiency virus (HIV) infection is linked to diverse vasculitic syndromes, including polyarteritis nodosa and central nervous system vasculitis. Management may require aggressive immunosuppression and antimicrobial prophylaxis.
Area of Science:
- Rheumatology
- Infectious Diseases
- Immunology
Background:
- Vasculitic syndromes encompass a range of inflammatory conditions affecting blood vessels.
- Infection with the human immunodeficiency virus (HIV) is increasingly recognized as a potential trigger or associated factor in various vasculitides.
- The spectrum of vasculitis associated with HIV infection mirrors that seen in the general population, but with unique considerations.
Purpose of the Study:
- To review the spectrum of vasculitic syndromes associated with HIV infection.
- To discuss the potential pathogenesis of HIV-associated vasculitis.
- To provide guidance on therapeutic approaches for managing these complex cases.
Main Methods:
- Literature review of reported cases of vasculitis in HIV-infected individuals.
- Analysis of clinical presentations, diagnostic findings, and treatment outcomes.
- Synthesis of current understanding regarding the pathophysiology and management strategies.
Main Results:
- HIV-associated vasculitis presents with diverse manifestations, including polyarteritis nodosa-like illness, hypersensitivity vasculitis, lymphomatoid granulomatosis, and primary angiitis of the central nervous system.
- The exact pathogenesis remains unclear, with evidence suggesting a role for HIV itself in some cases.
- Limited clinical data exist, highlighting the need for further research.
Conclusions:
- Vasculitic syndromes in HIV-infected patients represent a broad spectrum of disease.
- Pathogenesis may involve direct or indirect effects of HIV.
- Aggressive treatment strategies, including immunosuppression and antimicrobial prophylaxis, may be necessary for effective management.